Research Identifies How Glioblastoma Develops Resistance to Immunotherapy
Glioblastoma multiforme is an aggressive cancer that grows quickly and spreads rapidly, originating as a growth of cells in the spinal cord or the brain. Researchers at the University of Copenhagen may have discovered how this type of cancer, which primarily effects adults, develops resistance to immunotherapy. At first, the researchers thought that the cancer cells changed their DNA via mutation, helping them become treatment resistant. However, the researchers observed that when glioblastoma cells were subjected to immunotherapy, they behaved differently. Joachim Lütken Weischenfeldt, a clinical professor at the Biotech Research and Innovation Center, led this research. For their study,…
